WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry conference to blame insurers for making people pay too much for drugs.
America’s Health Insurance Plans CEO Matt Eyles, interviewing Pharmaceutical Research and Manufacturers of America President Stephen Ubl, asked for examples of policies that would benefit both industries. Ubl responded by suggesting that insurers lower cost sharing for drugs. He said spending on drugs rose about 1% last year and that the rebates that insurers get from drug makers continued to go up “exponentially.”
